avrg: GSE58827: Dynamics of the Mouse Liver
Gene Symbol | Gene ID | Gene Info |
---|---|---|
Zbtb18
|
ENSMUSG00000063659.12 | Zbtb18 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
Zbtb18 | mm39_v1_chr1_+_177273226_177273387 | -0.31 | 6.6e-02 | Click! |
Promoter | Score | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr8_-_112417633 | 25.34 |
ENSMUST00000034435.7
|
Ctrb1
|
chymotrypsinogen B1 |
chr8_-_106660470 | 15.53 |
ENSMUST00000034368.8
|
Ctrl
|
chymotrypsin-like |
chr14_+_30608433 | 10.23 |
ENSMUST00000120269.11
ENSMUST00000078490.14 ENSMUST00000006703.15 |
Itih4
|
inter alpha-trypsin inhibitor, heavy chain 4 |
chr14_+_30608478 | 10.11 |
ENSMUST00000168782.4
|
Itih4
|
inter alpha-trypsin inhibitor, heavy chain 4 |
chr6_-_41012435 | 10.08 |
ENSMUST00000031931.6
|
2210010C04Rik
|
RIKEN cDNA 2210010C04 gene |
chr4_-_115353326 | 9.81 |
ENSMUST00000030487.3
|
Cyp4a14
|
cytochrome P450, family 4, subfamily a, polypeptide 14 |
chr17_-_28779678 | 8.48 |
ENSMUST00000114785.3
ENSMUST00000025062.5 |
Clps
|
colipase, pancreatic |
chr17_-_12894716 | 8.48 |
ENSMUST00000024596.10
|
Slc22a1
|
solute carrier family 22 (organic cation transporter), member 1 |
chr17_-_84990360 | 8.36 |
ENSMUST00000066175.10
|
Abcg5
|
ATP binding cassette subfamily G member 5 |
chr12_-_103956176 | 6.88 |
ENSMUST00000151709.3
ENSMUST00000176246.3 ENSMUST00000074693.13 ENSMUST00000120251.9 |
Serpina11
|
serine (or cysteine) peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 11 |
chr9_-_103097022 | 6.58 |
ENSMUST00000168142.8
|
Trf
|
transferrin |
chr6_+_37507108 | 6.22 |
ENSMUST00000040987.11
|
Akr1d1
|
aldo-keto reductase family 1, member D1 |
chr4_+_115375461 | 5.90 |
ENSMUST00000058785.10
ENSMUST00000094886.4 |
Cyp4a10
|
cytochrome P450, family 4, subfamily a, polypeptide 10 |
chr10_+_62897353 | 5.82 |
ENSMUST00000178684.3
ENSMUST00000020266.15 |
Pbld1
|
phenazine biosynthesis-like protein domain containing 1 |
chr1_+_160806241 | 5.53 |
ENSMUST00000195760.2
|
Serpinc1
|
serine (or cysteine) peptidase inhibitor, clade C (antithrombin), member 1 |
chr17_+_84990541 | 5.48 |
ENSMUST00000045714.15
ENSMUST00000171915.2 |
Abcg8
|
ATP binding cassette subfamily G member 8 |
chr1_-_150341911 | 5.06 |
ENSMUST00000162367.8
ENSMUST00000161611.8 ENSMUST00000161320.8 ENSMUST00000159035.2 |
Prg4
|
proteoglycan 4 (megakaryocyte stimulating factor, articular superficial zone protein) |
chr19_+_34268053 | 4.99 |
ENSMUST00000025691.13
|
Fas
|
Fas (TNF receptor superfamily member 6) |
chr7_-_19432933 | 4.88 |
ENSMUST00000174355.8
ENSMUST00000172983.8 ENSMUST00000174710.2 ENSMUST00000003066.16 ENSMUST00000174064.9 |
Apoe
|
apolipoprotein E |
chr2_+_43445333 | 4.82 |
ENSMUST00000028223.9
ENSMUST00000112826.8 |
Kynu
|
kynureninase |
chr5_-_145406533 | 4.63 |
ENSMUST00000031633.5
|
Cyp3a16
|
cytochrome P450, family 3, subfamily a, polypeptide 16 |
chr11_+_98938137 | 4.56 |
ENSMUST00000140772.2
|
Igfbp4
|
insulin-like growth factor binding protein 4 |
chr14_+_40826970 | 4.56 |
ENSMUST00000225720.2
|
Mat1a
|
methionine adenosyltransferase I, alpha |
chr1_+_160806194 | 4.52 |
ENSMUST00000064725.11
ENSMUST00000191936.2 |
Serpinc1
|
serine (or cysteine) peptidase inhibitor, clade C (antithrombin), member 1 |
chr14_-_31362835 | 4.46 |
ENSMUST00000167066.8
ENSMUST00000127204.9 |
Hacl1
|
2-hydroxyacyl-CoA lyase 1 |
chr14_-_31362909 | 4.43 |
ENSMUST00000022437.16
|
Hacl1
|
2-hydroxyacyl-CoA lyase 1 |
chr19_+_34268071 | 4.33 |
ENSMUST00000112472.4
ENSMUST00000235232.2 |
Fas
|
Fas (TNF receptor superfamily member 6) |
chr1_-_139708906 | 4.19 |
ENSMUST00000111986.8
ENSMUST00000027612.11 ENSMUST00000111989.9 |
Cfhr4
|
complement factor H-related 4 |
chr1_-_139786421 | 4.18 |
ENSMUST00000194186.6
ENSMUST00000094489.5 ENSMUST00000239380.2 |
Cfhr2
|
complement factor H-related 2 |
chr7_-_14180496 | 4.10 |
ENSMUST00000063509.11
|
Sult2a8
|
sulfotransferase family 2A, dehydroepiandrosterone (DHEA)-preferring, member 8 |
chr8_-_25066313 | 4.06 |
ENSMUST00000121992.2
|
Ido2
|
indoleamine 2,3-dioxygenase 2 |
chr14_+_40827108 | 3.87 |
ENSMUST00000224514.2
|
Mat1a
|
methionine adenosyltransferase I, alpha |
chr6_+_70703409 | 3.87 |
ENSMUST00000103410.3
|
Igkc
|
immunoglobulin kappa constant |
chr5_+_135754568 | 3.80 |
ENSMUST00000127096.2
|
Por
|
P450 (cytochrome) oxidoreductase |
chr1_+_45350698 | 3.67 |
ENSMUST00000087883.13
|
Col3a1
|
collagen, type III, alpha 1 |
chr4_-_49506538 | 3.62 |
ENSMUST00000043056.9
|
Baat
|
bile acid-Coenzyme A: amino acid N-acyltransferase |
chr2_+_43445359 | 3.61 |
ENSMUST00000050511.7
|
Kynu
|
kynureninase |
chr4_+_115458172 | 3.58 |
ENSMUST00000084342.6
|
Cyp4a32
|
cytochrome P450, family 4, subfamily a, polypeptide 32 |
chr4_+_140970161 | 3.56 |
ENSMUST00000138096.8
ENSMUST00000006618.9 ENSMUST00000125392.8 |
Arhgef19
|
Rho guanine nucleotide exchange factor (GEF) 19 |
chr5_-_145521533 | 3.51 |
ENSMUST00000075837.8
|
Cyp3a41b
|
cytochrome P450, family 3, subfamily a, polypeptide 41B |
chr8_-_4155758 | 3.50 |
ENSMUST00000138439.2
ENSMUST00000145007.8 |
Cd209f
|
CD209f antigen |
chr5_+_135703426 | 3.43 |
ENSMUST00000153515.8
|
Por
|
P450 (cytochrome) oxidoreductase |
chr17_-_7652863 | 3.42 |
ENSMUST00000070059.5
|
Unc93a2
|
unc-93 homolog A2 |
chr14_-_123150497 | 3.42 |
ENSMUST00000162164.2
ENSMUST00000110679.9 ENSMUST00000161322.3 ENSMUST00000038075.12 |
Ggact
|
gamma-glutamylamine cyclotransferase |
chr7_-_79497940 | 3.39 |
ENSMUST00000107392.8
|
Anpep
|
alanyl (membrane) aminopeptidase |
chr14_+_40827317 | 3.37 |
ENSMUST00000047286.7
|
Mat1a
|
methionine adenosyltransferase I, alpha |
chr7_-_14180576 | 3.36 |
ENSMUST00000125941.3
|
Sult2a8
|
sulfotransferase family 2A, dehydroepiandrosterone (DHEA)-preferring, member 8 |
chr1_-_162694076 | 3.35 |
ENSMUST00000046049.14
|
Fmo1
|
flavin containing monooxygenase 1 |
chr3_-_108443769 | 3.32 |
ENSMUST00000048012.13
ENSMUST00000106625.10 |
Elapor1
|
endosome-lysosome associated apoptosis and autophagy regulator 1 |
chr5_-_145656934 | 3.29 |
ENSMUST00000094111.6
|
Cyp3a41a
|
cytochrome P450, family 3, subfamily a, polypeptide 41A |
chr16_+_26400454 | 3.15 |
ENSMUST00000096129.9
ENSMUST00000166294.9 ENSMUST00000174202.8 ENSMUST00000023156.13 |
Il1rap
|
interleukin 1 receptor accessory protein |
chr7_+_43874854 | 3.00 |
ENSMUST00000206144.2
|
Klk1
|
kallikrein 1 |
chr7_+_43874752 | 3.00 |
ENSMUST00000075162.5
|
Klk1
|
kallikrein 1 |
chr1_+_92934050 | 2.94 |
ENSMUST00000059676.5
|
Aqp12
|
aquaporin 12 |
chr8_+_13076024 | 2.87 |
ENSMUST00000033820.4
|
F7
|
coagulation factor VII |
chr4_-_115875055 | 2.84 |
ENSMUST00000049095.6
|
Faah
|
fatty acid amide hydrolase |
chr11_+_118319319 | 2.79 |
ENSMUST00000017590.9
|
C1qtnf1
|
C1q and tumor necrosis factor related protein 1 |
chr17_-_45997132 | 2.78 |
ENSMUST00000113523.9
|
Tmem63b
|
transmembrane protein 63b |
chr17_-_33166346 | 2.75 |
ENSMUST00000139353.8
|
Cyp4f13
|
cytochrome P450, family 4, subfamily f, polypeptide 13 |
chr2_-_25390625 | 2.73 |
ENSMUST00000040042.11
|
C8g
|
complement component 8, gamma polypeptide |
chr11_+_120421496 | 2.69 |
ENSMUST00000026119.8
|
Gcgr
|
glucagon receptor |
chr6_+_72332449 | 2.68 |
ENSMUST00000206064.2
|
Tmem150a
|
transmembrane protein 150A |
chr17_-_45997046 | 2.65 |
ENSMUST00000143907.3
ENSMUST00000127065.8 |
Tmem63b
|
transmembrane protein 63b |
chr1_+_87998487 | 2.62 |
ENSMUST00000073772.5
|
Ugt1a9
|
UDP glucuronosyltransferase 1 family, polypeptide A9 |
chr6_+_72332423 | 2.61 |
ENSMUST00000069695.9
ENSMUST00000132243.3 |
Tmem150a
|
transmembrane protein 150A |
chr11_-_75313350 | 2.52 |
ENSMUST00000125982.2
ENSMUST00000137103.8 |
Serpinf1
|
serine (or cysteine) peptidase inhibitor, clade F, member 1 |
chr1_-_170804116 | 2.50 |
ENSMUST00000159969.8
|
Fcgr2b
|
Fc receptor, IgG, low affinity IIb |
chr17_-_45996899 | 2.49 |
ENSMUST00000145873.8
|
Tmem63b
|
transmembrane protein 63b |
chr1_+_164624200 | 2.45 |
ENSMUST00000027861.6
|
Dpt
|
dermatopontin |
chr11_-_75313412 | 2.35 |
ENSMUST00000138661.8
ENSMUST00000000769.14 |
Serpinf1
|
serine (or cysteine) peptidase inhibitor, clade F, member 1 |
chr3_+_107137924 | 2.33 |
ENSMUST00000179399.3
|
A630076J17Rik
|
RIKEN cDNA A630076J17 gene |
chr9_-_36708599 | 2.33 |
ENSMUST00000238932.2
ENSMUST00000115086.13 |
Ei24
|
etoposide induced 2.4 mRNA |
chr13_+_30520416 | 2.25 |
ENSMUST00000222503.2
ENSMUST00000222370.2 ENSMUST00000066412.8 ENSMUST00000223201.2 |
Agtr1a
|
angiotensin II receptor, type 1a |
chr9_+_43978290 | 2.22 |
ENSMUST00000034508.14
|
Usp2
|
ubiquitin specific peptidase 2 |
chr8_+_4184652 | 2.12 |
ENSMUST00000130372.3
|
Cd209g
|
CD209g antigen |
chr6_+_87405968 | 2.11 |
ENSMUST00000032125.7
|
Bmp10
|
bone morphogenetic protein 10 |
chr1_-_180021039 | 2.11 |
ENSMUST00000160482.8
ENSMUST00000170472.8 |
Coq8a
|
coenzyme Q8A |
chr16_-_22848153 | 2.09 |
ENSMUST00000232459.2
|
Kng2
|
kininogen 2 |
chr10_-_93375832 | 2.08 |
ENSMUST00000016034.3
|
Amdhd1
|
amidohydrolase domain containing 1 |
chr15_+_31568937 | 2.01 |
ENSMUST00000162532.8
ENSMUST00000070918.14 |
Cmbl
|
carboxymethylenebutenolidase-like (Pseudomonas) |
chr17_-_33166362 | 1.97 |
ENSMUST00000234083.2
ENSMUST00000075253.13 |
Cyp4f13
|
cytochrome P450, family 4, subfamily f, polypeptide 13 |
chr15_-_96918203 | 1.89 |
ENSMUST00000166223.2
|
Slc38a4
|
solute carrier family 38, member 4 |
chr5_-_38649291 | 1.89 |
ENSMUST00000129099.8
|
Slc2a9
|
solute carrier family 2 (facilitated glucose transporter), member 9 |
chr7_-_79497922 | 1.88 |
ENSMUST00000205502.2
|
Anpep
|
alanyl (membrane) aminopeptidase |
chr11_-_109986804 | 1.82 |
ENSMUST00000100287.9
|
Abca8a
|
ATP-binding cassette, sub-family A (ABC1), member 8a |
chr11_+_49500090 | 1.81 |
ENSMUST00000020617.3
|
Flt4
|
FMS-like tyrosine kinase 4 |
chr2_-_27137272 | 1.80 |
ENSMUST00000102886.10
ENSMUST00000129975.2 |
Sardh
|
sarcosine dehydrogenase |
chr12_+_29988035 | 1.79 |
ENSMUST00000122328.8
ENSMUST00000118321.3 |
Pxdn
|
peroxidasin |
chr14_+_31363004 | 1.77 |
ENSMUST00000090147.7
|
Btd
|
biotinidase |
chr17_-_13350642 | 1.74 |
ENSMUST00000232960.2
ENSMUST00000084966.6 ENSMUST00000233405.2 |
Unc93a
|
unc-93 homolog A |
chr17_-_84154196 | 1.73 |
ENSMUST00000234214.2
|
Haao
|
3-hydroxyanthranilate 3,4-dioxygenase |
chr14_+_40873399 | 1.73 |
ENSMUST00000225792.2
|
Mbl1
|
mannose-binding lectin (protein A) 1 |
chr11_-_109986763 | 1.67 |
ENSMUST00000046223.14
ENSMUST00000106664.10 ENSMUST00000106662.2 |
Abca8a
|
ATP-binding cassette, sub-family A (ABC1), member 8a |
chr4_-_44066960 | 1.65 |
ENSMUST00000173234.8
ENSMUST00000173274.2 |
Gne
|
glucosamine (UDP-N-acetyl)-2-epimerase/N-acetylmannosamine kinase |
chr11_-_114952984 | 1.65 |
ENSMUST00000062787.8
|
Cd300e
|
CD300E molecule |
chr6_+_112250719 | 1.64 |
ENSMUST00000032376.6
|
Lmcd1
|
LIM and cysteine-rich domains 1 |
chr9_-_63306497 | 1.61 |
ENSMUST00000168665.3
|
2300009A05Rik
|
RIKEN cDNA 2300009A05 gene |
chr1_-_170755136 | 1.60 |
ENSMUST00000046322.14
ENSMUST00000159171.2 |
Fcrla
|
Fc receptor-like A |
chr9_+_108174052 | 1.59 |
ENSMUST00000035230.7
|
Amt
|
aminomethyltransferase |
chr6_-_6217126 | 1.58 |
ENSMUST00000188414.4
|
Slc25a13
|
solute carrier family 25 (mitochondrial carrier, adenine nucleotide translocator), member 13 |
chr7_-_45679703 | 1.57 |
ENSMUST00000002850.8
|
Abcc6
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 6 |
chr16_-_56984137 | 1.52 |
ENSMUST00000231733.2
|
Nit2
|
nitrilase family, member 2 |
chr5_-_120610828 | 1.52 |
ENSMUST00000052258.14
ENSMUST00000031594.13 |
Sdsl
|
serine dehydratase-like |
chr6_+_91134358 | 1.52 |
ENSMUST00000155007.2
|
Hdac11
|
histone deacetylase 11 |
chr6_+_91133755 | 1.52 |
ENSMUST00000143621.8
|
Hdac11
|
histone deacetylase 11 |
chr6_+_72333209 | 1.51 |
ENSMUST00000206531.2
|
Tmem150a
|
transmembrane protein 150A |
chr6_-_35303057 | 1.51 |
ENSMUST00000051176.9
|
Fam180a
|
family with sequence similarity 180, member A |
chr10_-_76562002 | 1.50 |
ENSMUST00000001147.5
|
Col6a1
|
collagen, type VI, alpha 1 |
chr2_-_150746574 | 1.44 |
ENSMUST00000056149.15
|
Abhd12
|
abhydrolase domain containing 12 |
chr11_+_118319029 | 1.44 |
ENSMUST00000124861.2
|
C1qtnf1
|
C1q and tumor necrosis factor related protein 1 |
chr12_-_58315949 | 1.44 |
ENSMUST00000062254.4
|
Clec14a
|
C-type lectin domain family 14, member a |
chr12_-_101785307 | 1.44 |
ENSMUST00000021603.9
|
Fbln5
|
fibulin 5 |
chr5_+_137348363 | 1.43 |
ENSMUST00000061244.15
|
Ephb4
|
Eph receptor B4 |
chr7_-_98010478 | 1.43 |
ENSMUST00000094161.11
ENSMUST00000164726.8 ENSMUST00000206414.2 ENSMUST00000167405.3 |
Tsku
|
tsukushi, small leucine rich proteoglycan |
chr4_-_130172998 | 1.42 |
ENSMUST00000120126.9
|
Serinc2
|
serine incorporator 2 |
chr9_+_65537834 | 1.41 |
ENSMUST00000055844.10
|
Rbpms2
|
RNA binding protein with multiple splicing 2 |
chr15_+_31225302 | 1.41 |
ENSMUST00000186425.7
|
Dap
|
death-associated protein |
chr4_-_44073016 | 1.39 |
ENSMUST00000128439.8
ENSMUST00000140724.3 |
Gne
|
glucosamine (UDP-N-acetyl)-2-epimerase/N-acetylmannosamine kinase |
chr6_+_91133647 | 1.38 |
ENSMUST00000041736.11
|
Hdac11
|
histone deacetylase 11 |
chr2_-_168576155 | 1.37 |
ENSMUST00000109175.9
|
Atp9a
|
ATPase, class II, type 9A |
chr13_+_58954447 | 1.37 |
ENSMUST00000224259.2
|
Ntrk2
|
neurotrophic tyrosine kinase, receptor, type 2 |
chr1_-_170755109 | 1.35 |
ENSMUST00000162136.2
ENSMUST00000162887.2 |
Fcrla
|
Fc receptor-like A |
chr9_-_58462720 | 1.34 |
ENSMUST00000165365.3
|
Cd276
|
CD276 antigen |
chr11_-_68848271 | 1.31 |
ENSMUST00000108671.2
|
Arhgef15
|
Rho guanine nucleotide exchange factor (GEF) 15 |
chr7_-_63588610 | 1.31 |
ENSMUST00000063694.10
|
Klf13
|
Kruppel-like factor 13 |
chr18_+_45402018 | 1.29 |
ENSMUST00000183850.8
ENSMUST00000066890.14 |
Kcnn2
|
potassium intermediate/small conductance calcium-activated channel, subfamily N, member 2 |
chr18_-_12995261 | 1.27 |
ENSMUST00000234427.2
|
Osbpl1a
|
oxysterol binding protein-like 1A |
chr17_+_73433422 | 1.24 |
ENSMUST00000232703.2
|
Lclat1
|
lysocardiolipin acyltransferase 1 |
chr16_+_22926504 | 1.23 |
ENSMUST00000187168.7
ENSMUST00000232287.2 ENSMUST00000077605.12 |
Eif4a2
|
eukaryotic translation initiation factor 4A2 |
chr17_+_45997248 | 1.23 |
ENSMUST00000024734.8
|
Mrpl14
|
mitochondrial ribosomal protein L14 |
chr7_-_126497421 | 1.22 |
ENSMUST00000121532.8
ENSMUST00000032926.12 |
Tmem219
|
transmembrane protein 219 |
chr1_-_14826208 | 1.21 |
ENSMUST00000027062.7
|
Msc
|
musculin |
chr7_+_126549692 | 1.20 |
ENSMUST00000106335.8
ENSMUST00000146017.3 |
Sez6l2
|
seizure related 6 homolog like 2 |
chr4_+_43414696 | 1.17 |
ENSMUST00000131668.3
|
Rusc2
|
RUN and SH3 domain containing 2 |
chr11_-_53313950 | 1.17 |
ENSMUST00000036045.6
|
Leap2
|
liver-expressed antimicrobial peptide 2 |
chr8_+_56747613 | 1.15 |
ENSMUST00000034026.10
|
Hpgd
|
hydroxyprostaglandin dehydrogenase 15 (NAD) |
chr11_-_69553451 | 1.15 |
ENSMUST00000018905.12
|
Mpdu1
|
mannose-P-dolichol utilization defect 1 |
chr16_-_94327689 | 1.15 |
ENSMUST00000023615.7
|
Vps26c
|
VPS26 endosomal protein sorting factor C |
chr4_-_130169335 | 1.14 |
ENSMUST00000154846.2
ENSMUST00000105996.8 |
Serinc2
|
serine incorporator 2 |
chr6_+_68026941 | 1.13 |
ENSMUST00000103316.2
|
Igkv9-120
|
immunoglobulin kappa chain variable 9-120 |
chr10_-_95159933 | 1.12 |
ENSMUST00000053594.7
|
Cradd
|
CASP2 and RIPK1 domain containing adaptor with death domain |
chr13_+_43938251 | 1.11 |
ENSMUST00000015540.4
|
Cd83
|
CD83 antigen |
chr4_-_107889267 | 1.10 |
ENSMUST00000106709.9
|
Podn
|
podocan |
chr6_+_78382131 | 1.10 |
ENSMUST00000023906.4
|
Reg2
|
regenerating islet-derived 2 |
chr2_+_84880776 | 1.10 |
ENSMUST00000111605.9
|
Tnks1bp1
|
tankyrase 1 binding protein 1 |
chr3_-_88460166 | 1.09 |
ENSMUST00000119002.2
ENSMUST00000029698.15 |
Lamtor2
|
late endosomal/lysosomal adaptor, MAPK and MTOR activator 2 |
chrX_-_7884688 | 1.08 |
ENSMUST00000033503.3
|
Glod5
|
glyoxalase domain containing 5 |
chr8_-_37200051 | 1.08 |
ENSMUST00000098826.10
|
Dlc1
|
deleted in liver cancer 1 |
chr9_+_65536892 | 1.08 |
ENSMUST00000169003.8
|
Rbpms2
|
RNA binding protein with multiple splicing 2 |
chr7_+_107166925 | 1.07 |
ENSMUST00000239087.2
|
Olfml1
|
olfactomedin-like 1 |
chr14_-_20231871 | 1.06 |
ENSMUST00000024011.10
|
Kcnk5
|
potassium channel, subfamily K, member 5 |
chr15_-_98660873 | 1.04 |
ENSMUST00000156572.3
|
Arf3
|
ADP-ribosylation factor 3 |
chr9_+_43978369 | 1.04 |
ENSMUST00000177054.8
|
Usp2
|
ubiquitin specific peptidase 2 |
chr2_+_127267069 | 1.02 |
ENSMUST00000062211.4
|
Gpat2
|
glycerol-3-phosphate acyltransferase 2, mitochondrial |
chr2_+_10085411 | 1.02 |
ENSMUST00000042512.8
|
Kin
|
Kin17 DNA and RNA binding protein |
chr5_+_87148697 | 1.01 |
ENSMUST00000031186.9
|
Ugt2b35
|
UDP glucuronosyltransferase 2 family, polypeptide B35 |
chr3_-_88366159 | 1.01 |
ENSMUST00000147200.8
ENSMUST00000169222.8 |
Sema4a
|
sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4A |
chr7_-_98010534 | 1.00 |
ENSMUST00000165257.8
|
Tsku
|
tsukushi, small leucine rich proteoglycan |
chr4_-_107889136 | 1.00 |
ENSMUST00000106708.8
|
Podn
|
podocan |
chr5_-_92475927 | 0.99 |
ENSMUST00000113093.5
|
Cxcl9
|
chemokine (C-X-C motif) ligand 9 |
chr12_+_88327607 | 0.97 |
ENSMUST00000166940.3
|
Adck1
|
aarF domain containing kinase 1 |
chr5_-_108596960 | 0.95 |
ENSMUST00000031455.5
|
Mfsd7a
|
major facilitator superfamily domain containing 7A |
chr11_+_101221431 | 0.94 |
ENSMUST00000103105.10
|
Aoc3
|
amine oxidase, copper containing 3 |
chr11_+_95733489 | 0.94 |
ENSMUST00000100532.10
ENSMUST00000036088.11 |
Gngt2
|
guanine nucleotide binding protein (G protein), gamma transducing activity polypeptide 2 |
chr11_-_69553390 | 0.94 |
ENSMUST00000129224.8
ENSMUST00000155200.8 |
Mpdu1
|
mannose-P-dolichol utilization defect 1 |
chr11_+_80044931 | 0.93 |
ENSMUST00000021050.14
|
Adap2
|
ArfGAP with dual PH domains 2 |
chr14_-_63746541 | 0.93 |
ENSMUST00000022522.15
|
Tdh
|
L-threonine dehydrogenase |
chr2_+_144435974 | 0.92 |
ENSMUST00000136628.2
|
Smim26
|
small integral membrane protein 26 |
chr11_-_106641454 | 0.92 |
ENSMUST00000068021.9
|
Pecam1
|
platelet/endothelial cell adhesion molecule 1 |
chr7_-_28078671 | 0.90 |
ENSMUST00000209061.2
|
Zfp36
|
zinc finger protein 36 |
chr11_+_87473027 | 0.90 |
ENSMUST00000133202.3
|
Septin4
|
septin 4 |
chr15_-_103248512 | 0.89 |
ENSMUST00000168828.3
|
Zfp385a
|
zinc finger protein 385A |
chr18_+_11972277 | 0.89 |
ENSMUST00000171109.9
ENSMUST00000046948.10 |
Cables1
|
CDK5 and Abl enzyme substrate 1 |
chr4_-_149569614 | 0.89 |
ENSMUST00000126896.2
ENSMUST00000105693.2 ENSMUST00000030845.13 |
Nmnat1
|
nicotinamide nucleotide adenylyltransferase 1 |
chr9_-_116004386 | 0.88 |
ENSMUST00000035014.8
|
Tgfbr2
|
transforming growth factor, beta receptor II |
chr7_-_97387429 | 0.88 |
ENSMUST00000206389.2
|
Aqp11
|
aquaporin 11 |
chr17_+_11059309 | 0.87 |
ENSMUST00000233706.2
|
Prkn
|
parkin RBR E3 ubiquitin protein ligase |
chr18_-_12995395 | 0.86 |
ENSMUST00000121888.8
|
Osbpl1a
|
oxysterol binding protein-like 1A |
chr12_+_88327391 | 0.85 |
ENSMUST00000222695.2
|
Adck1
|
aarF domain containing kinase 1 |
chr13_+_74787952 | 0.84 |
ENSMUST00000221822.2
ENSMUST00000221526.2 |
Erap1
|
endoplasmic reticulum aminopeptidase 1 |
chr2_+_68966125 | 0.84 |
ENSMUST00000041865.8
|
Nostrin
|
nitric oxide synthase trafficker |
chr6_+_90443293 | 0.84 |
ENSMUST00000203607.2
|
Klf15
|
Kruppel-like factor 15 |
chr7_+_126549859 | 0.84 |
ENSMUST00000106333.8
|
Sez6l2
|
seizure related 6 homolog like 2 |
chr17_-_34000804 | 0.83 |
ENSMUST00000002360.17
|
Angptl4
|
angiopoietin-like 4 |
chr3_+_121220146 | 0.83 |
ENSMUST00000029773.13
|
Cnn3
|
calponin 3, acidic |
chr10_+_59715439 | 0.83 |
ENSMUST00000142819.8
ENSMUST00000020309.7 |
Dnajb12
|
DnaJ heat shock protein family (Hsp40) member B12 |
chr3_-_88366351 | 0.83 |
ENSMUST00000165898.8
ENSMUST00000127436.8 |
Sema4a
|
sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4A |
chr17_-_66826661 | 0.82 |
ENSMUST00000167962.2
ENSMUST00000070538.12 |
Rab12
|
RAB12, member RAS oncogene family |
chr5_-_36987917 | 0.82 |
ENSMUST00000031002.10
|
Man2b2
|
mannosidase 2, alpha B2 |
chr17_-_36290129 | 0.81 |
ENSMUST00000165613.9
ENSMUST00000173872.8 |
Prr3
|
proline-rich polypeptide 3 |
chr12_+_88327305 | 0.81 |
ENSMUST00000101165.9
|
Adck1
|
aarF domain containing kinase 1 |
chr7_+_3696601 | 0.81 |
ENSMUST00000123088.8
ENSMUST00000205287.2 ENSMUST00000038521.14 ENSMUST00000108629.8 ENSMUST00000142713.2 |
Tsen34
|
tRNA splicing endonuclease subunit 34 |
chr7_-_44711075 | 0.81 |
ENSMUST00000007981.9
ENSMUST00000210500.2 ENSMUST00000210493.2 |
Prrg2
|
proline-rich Gla (G-carboxyglutamic acid) polypeptide 2 |
chr16_-_10810964 | 0.81 |
ENSMUST00000023143.14
|
Litaf
|
LPS-induced TN factor |
chr4_+_155924181 | 0.80 |
ENSMUST00000030947.4
|
Mxra8
|
matrix-remodelling associated 8 |
chr2_-_65069383 | 0.80 |
ENSMUST00000155916.8
ENSMUST00000156643.2 |
Cobll1
|
Cobl-like 1 |
chr18_+_84869456 | 0.78 |
ENSMUST00000160180.9
|
Cyb5a
|
cytochrome b5 type A (microsomal) |
chrX_-_161426542 | 0.78 |
ENSMUST00000101102.2
|
Reps2
|
RALBP1 associated Eps domain containing protein 2 |
chr3_-_96812610 | 0.78 |
ENSMUST00000029738.14
|
Gpr89
|
G protein-coupled receptor 89 |
chr10_+_53213763 | 0.78 |
ENSMUST00000219491.2
ENSMUST00000163319.9 ENSMUST00000220197.2 ENSMUST00000046221.8 ENSMUST00000218468.2 ENSMUST00000219921.2 |
Pln
|
phospholamban |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.9 | 11.8 | GO:0009087 | methionine catabolic process(GO:0009087) |
2.9 | 8.7 | GO:0031104 | dendrite regeneration(GO:0031104) |
2.8 | 8.4 | GO:0019442 | tryptophan catabolic process to acetyl-CoA(GO:0019442) |
2.3 | 13.8 | GO:1904479 | negative regulation of intestinal absorption(GO:1904479) |
2.1 | 6.2 | GO:0030573 | bile acid catabolic process(GO:0030573) |
1.9 | 5.8 | GO:0060392 | negative regulation of SMAD protein import into nucleus(GO:0060392) |
1.8 | 7.2 | GO:0046210 | nitrate catabolic process(GO:0043602) nitric oxide catabolic process(GO:0046210) cellular organohalogen metabolic process(GO:0090345) cellular organofluorine metabolic process(GO:0090346) |
1.6 | 4.9 | GO:1903000 | regulation of lipid transport across blood brain barrier(GO:1903000) positive regulation of lipid transport across blood brain barrier(GO:1903002) |
1.3 | 8.9 | GO:0001561 | fatty acid alpha-oxidation(GO:0001561) |
1.3 | 10.1 | GO:0007597 | blood coagulation, intrinsic pathway(GO:0007597) |
1.3 | 7.5 | GO:0010248 | establishment or maintenance of transmembrane electrochemical gradient(GO:0010248) |
0.8 | 6.6 | GO:0070447 | positive regulation of oligodendrocyte progenitor proliferation(GO:0070447) |
0.8 | 1.6 | GO:0002514 | B cell tolerance induction(GO:0002514) regulation of B cell tolerance induction(GO:0002661) positive regulation of B cell tolerance induction(GO:0002663) |
0.7 | 2.2 | GO:0086097 | phospholipase C-activating angiotensin-activated signaling pathway(GO:0086097) |
0.7 | 3.7 | GO:0060414 | aorta smooth muscle tissue morphogenesis(GO:0060414) |
0.6 | 2.5 | GO:0002884 | immune response-regulating cell surface receptor signaling pathway involved in phagocytosis(GO:0002433) negative regulation of hypersensitivity(GO:0002884) Fc-gamma receptor signaling pathway involved in phagocytosis(GO:0038096) |
0.6 | 1.8 | GO:1901052 | sarcosine metabolic process(GO:1901052) sarcosine catabolic process(GO:1901053) |
0.6 | 5.1 | GO:0045409 | negative regulation of interleukin-6 biosynthetic process(GO:0045409) |
0.5 | 1.6 | GO:0006546 | glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
0.5 | 4.1 | GO:0019441 | tryptophan catabolic process(GO:0006569) tryptophan catabolic process to kynurenine(GO:0019441) indole-containing compound catabolic process(GO:0042436) indolalkylamine catabolic process(GO:0046218) |
0.5 | 2.4 | GO:0061073 | ciliary body morphogenesis(GO:0061073) |
0.5 | 1.4 | GO:0046462 | monoacylglycerol metabolic process(GO:0046462) |
0.5 | 2.9 | GO:0010641 | positive regulation of platelet-derived growth factor receptor signaling pathway(GO:0010641) |
0.4 | 3.1 | GO:1904219 | regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
0.4 | 2.1 | GO:0006548 | histidine catabolic process(GO:0006548) |
0.4 | 4.9 | GO:0060770 | negative regulation of epithelial cell proliferation involved in prostate gland development(GO:0060770) |
0.4 | 1.6 | GO:0048388 | endosomal lumen acidification(GO:0048388) |
0.4 | 0.4 | GO:1901630 | negative regulation of presynaptic membrane organization(GO:1901630) |
0.4 | 4.0 | GO:2000860 | positive regulation of mineralocorticoid secretion(GO:2000857) positive regulation of aldosterone secretion(GO:2000860) |
0.4 | 2.1 | GO:2000525 | regulation of T cell costimulation(GO:2000523) positive regulation of T cell costimulation(GO:2000525) |
0.3 | 16.4 | GO:0030212 | hyaluronan metabolic process(GO:0030212) |
0.3 | 1.7 | GO:0046874 | quinolinate metabolic process(GO:0046874) |
0.3 | 2.7 | GO:0033762 | response to glucagon(GO:0033762) |
0.3 | 2.0 | GO:0099540 | synaptic signaling via neuropeptide(GO:0099538) trans-synaptic signaling by neuropeptide(GO:0099540) trans-synaptic signaling by neuropeptide, modulating synaptic transmission(GO:0099551) |
0.3 | 1.3 | GO:2000297 | negative regulation of synapse maturation(GO:2000297) |
0.3 | 1.6 | GO:0043490 | malate-aspartate shuttle(GO:0043490) |
0.3 | 0.9 | GO:0006566 | threonine metabolic process(GO:0006566) |
0.3 | 0.9 | GO:0090673 | endothelial cell-matrix adhesion(GO:0090673) |
0.3 | 1.2 | GO:0014707 | branchiomeric skeletal muscle development(GO:0014707) |
0.3 | 3.6 | GO:0006544 | glycine metabolic process(GO:0006544) |
0.3 | 0.9 | GO:1904582 | regulation of intracellular mRNA localization(GO:1904580) positive regulation of intracellular mRNA localization(GO:1904582) |
0.3 | 5.0 | GO:0043568 | positive regulation of insulin-like growth factor receptor signaling pathway(GO:0043568) |
0.3 | 3.0 | GO:0072602 | interleukin-4 secretion(GO:0072602) |
0.3 | 5.3 | GO:0035814 | negative regulation of renal sodium excretion(GO:0035814) |
0.2 | 0.5 | GO:0060825 | fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:0060825) regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:2000313) |
0.2 | 0.7 | GO:2000097 | regulation of smooth muscle cell-matrix adhesion(GO:2000097) |
0.2 | 2.1 | GO:2000138 | positive regulation of cell proliferation involved in heart morphogenesis(GO:2000138) |
0.2 | 2.3 | GO:0071494 | cellular response to UV-C(GO:0071494) |
0.2 | 0.7 | GO:0030200 | heparan sulfate proteoglycan catabolic process(GO:0030200) |
0.2 | 1.1 | GO:0032917 | polyamine acetylation(GO:0032917) spermidine acetylation(GO:0032918) |
0.2 | 0.9 | GO:0010609 | mRNA localization resulting in posttranscriptional regulation of gene expression(GO:0010609) |
0.2 | 2.6 | GO:0052696 | flavonoid glucuronidation(GO:0052696) xenobiotic glucuronidation(GO:0052697) |
0.2 | 1.5 | GO:0045077 | negative regulation of interferon-gamma biosynthetic process(GO:0045077) |
0.2 | 33.8 | GO:0007586 | digestion(GO:0007586) |
0.2 | 3.7 | GO:0006054 | N-acetylneuraminate metabolic process(GO:0006054) |
0.2 | 0.6 | GO:0060671 | epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
0.2 | 2.5 | GO:0051151 | negative regulation of smooth muscle cell differentiation(GO:0051151) |
0.2 | 3.3 | GO:0070995 | NADPH oxidation(GO:0070995) |
0.2 | 1.0 | GO:0003376 | sphingosine-1-phosphate signaling pathway(GO:0003376) |
0.2 | 6.4 | GO:0046854 | phosphatidylinositol phosphorylation(GO:0046854) |
0.2 | 2.7 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
0.2 | 0.8 | GO:0060857 | establishment of glial blood-brain barrier(GO:0060857) |
0.2 | 1.1 | GO:0032713 | negative regulation of interleukin-4 production(GO:0032713) |
0.2 | 0.5 | GO:0090076 | maintenance of mitochondrion location(GO:0051659) relaxation of skeletal muscle(GO:0090076) |
0.2 | 0.6 | GO:1902037 | negative regulation of hematopoietic stem cell differentiation(GO:1902037) |
0.2 | 4.6 | GO:0006691 | leukotriene metabolic process(GO:0006691) |
0.1 | 3.4 | GO:0042219 | cellular modified amino acid catabolic process(GO:0042219) |
0.1 | 1.4 | GO:2000121 | regulation of removal of superoxide radicals(GO:2000121) |
0.1 | 0.8 | GO:0051005 | negative regulation of lipoprotein lipase activity(GO:0051005) |
0.1 | 0.3 | GO:0002760 | positive regulation of antimicrobial humoral response(GO:0002760) negative regulation of toll-like receptor 2 signaling pathway(GO:0034136) |
0.1 | 1.7 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
0.1 | 2.1 | GO:0006488 | dolichol-linked oligosaccharide biosynthetic process(GO:0006488) |
0.1 | 3.3 | GO:0048642 | negative regulation of skeletal muscle tissue development(GO:0048642) |
0.1 | 0.5 | GO:1900220 | semaphorin-plexin signaling pathway involved in bone trabecula morphogenesis(GO:1900220) |
0.1 | 1.8 | GO:0090037 | positive regulation of protein kinase C signaling(GO:0090037) |
0.1 | 1.7 | GO:0007567 | parturition(GO:0007567) |
0.1 | 0.7 | GO:0006172 | ADP biosynthetic process(GO:0006172) |
0.1 | 0.9 | GO:0035902 | response to immobilization stress(GO:0035902) |
0.1 | 0.9 | GO:0034316 | negative regulation of Arp2/3 complex-mediated actin nucleation(GO:0034316) |
0.1 | 0.7 | GO:0000042 | protein targeting to Golgi(GO:0000042) |
0.1 | 0.6 | GO:0071718 | sodium-independent icosanoid transport(GO:0071718) |
0.1 | 0.2 | GO:0010726 | positive regulation of hydrogen peroxide metabolic process(GO:0010726) |
0.1 | 0.3 | GO:0003273 | cell migration involved in endocardial cushion formation(GO:0003273) negative regulation of vitamin D receptor signaling pathway(GO:0070563) |
0.1 | 1.8 | GO:1900119 | positive regulation of execution phase of apoptosis(GO:1900119) |
0.1 | 1.1 | GO:0006072 | glycerol-3-phosphate metabolic process(GO:0006072) |
0.1 | 2.0 | GO:0090036 | regulation of protein kinase C signaling(GO:0090036) |
0.1 | 0.6 | GO:0019355 | nicotinamide nucleotide biosynthetic process from aspartate(GO:0019355) 'de novo' NAD biosynthetic process(GO:0034627) 'de novo' NAD biosynthetic process from aspartate(GO:0034628) |
0.1 | 0.5 | GO:0051562 | negative regulation of mitochondrial calcium ion concentration(GO:0051562) |
0.1 | 1.9 | GO:0046415 | urate metabolic process(GO:0046415) |
0.1 | 2.1 | GO:0006744 | ubiquinone biosynthetic process(GO:0006744) |
0.1 | 0.3 | GO:2000077 | transepithelial water transport(GO:0035377) positive regulation of cyclic nucleotide-gated ion channel activity(GO:1902161) regulation of voltage-gated chloride channel activity(GO:1902941) positive regulation of voltage-gated chloride channel activity(GO:1902943) positive regulation of establishment of Sertoli cell barrier(GO:1904446) negative regulation of type B pancreatic cell development(GO:2000077) |
0.1 | 1.6 | GO:0070886 | positive regulation of calcineurin-NFAT signaling cascade(GO:0070886) |
0.1 | 0.3 | GO:0098749 | cerebellar neuron development(GO:0098749) |
0.1 | 1.6 | GO:0032780 | negative regulation of ATPase activity(GO:0032780) |
0.1 | 0.2 | GO:0060157 | urinary bladder development(GO:0060157) |
0.1 | 4.4 | GO:0014003 | oligodendrocyte development(GO:0014003) |
0.1 | 1.2 | GO:0070389 | chaperone cofactor-dependent protein refolding(GO:0070389) |
0.1 | 0.4 | GO:0097498 | endothelial tube lumen extension(GO:0097498) |
0.1 | 0.7 | GO:0061709 | reticulophagy(GO:0061709) |
0.1 | 0.8 | GO:0086023 | adrenergic receptor signaling pathway involved in heart process(GO:0086023) |
0.1 | 0.2 | GO:0007290 | spermatid nucleus elongation(GO:0007290) |
0.1 | 0.8 | GO:0006013 | mannose metabolic process(GO:0006013) |
0.1 | 1.5 | GO:0070935 | 3'-UTR-mediated mRNA stabilization(GO:0070935) |
0.1 | 1.3 | GO:0045647 | negative regulation of erythrocyte differentiation(GO:0045647) |
0.1 | 0.6 | GO:0009407 | toxin catabolic process(GO:0009407) secondary metabolite catabolic process(GO:0090487) |
0.1 | 0.6 | GO:1901097 | negative regulation of autophagosome maturation(GO:1901097) |
0.1 | 1.8 | GO:0042744 | hydrogen peroxide catabolic process(GO:0042744) |
0.1 | 0.3 | GO:0070173 | regulation of enamel mineralization(GO:0070173) |
0.1 | 0.4 | GO:0000255 | allantoin metabolic process(GO:0000255) |
0.1 | 0.6 | GO:0006703 | estrogen biosynthetic process(GO:0006703) |
0.1 | 0.3 | GO:0070829 | heterochromatin maintenance(GO:0070829) |
0.1 | 3.1 | GO:0006890 | retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
0.1 | 0.3 | GO:2000657 | regulation of apolipoprotein binding(GO:2000656) negative regulation of apolipoprotein binding(GO:2000657) |
0.1 | 0.2 | GO:0015882 | L-ascorbic acid transport(GO:0015882) transepithelial L-ascorbic acid transport(GO:0070904) |
0.1 | 0.4 | GO:0009405 | pathogenesis(GO:0009405) |
0.1 | 1.8 | GO:0045063 | T-helper 1 cell differentiation(GO:0045063) |
0.1 | 0.4 | GO:0001880 | Mullerian duct regression(GO:0001880) |
0.1 | 0.2 | GO:2001245 | regulation of phosphatidylcholine biosynthetic process(GO:2001245) |
0.1 | 0.8 | GO:0019885 | antigen processing and presentation of endogenous peptide antigen via MHC class I(GO:0019885) |
0.1 | 1.5 | GO:0070208 | protein heterotrimerization(GO:0070208) |
0.1 | 1.5 | GO:0006767 | water-soluble vitamin metabolic process(GO:0006767) |
0.1 | 0.4 | GO:2001183 | negative regulation of interleukin-12 secretion(GO:2001183) |
0.1 | 1.0 | GO:0010818 | T cell chemotaxis(GO:0010818) |
0.1 | 2.4 | GO:1900047 | negative regulation of blood coagulation(GO:0030195) negative regulation of hemostasis(GO:1900047) |
0.0 | 0.4 | GO:0002035 | brain renin-angiotensin system(GO:0002035) |
0.0 | 0.3 | GO:0009957 | epidermal cell fate specification(GO:0009957) |
0.0 | 0.1 | GO:0021526 | medial motor column neuron differentiation(GO:0021526) |
0.0 | 2.6 | GO:0030199 | collagen fibril organization(GO:0030199) |
0.0 | 0.7 | GO:0035721 | intraciliary retrograde transport(GO:0035721) |
0.0 | 0.8 | GO:0042347 | negative regulation of NF-kappaB import into nucleus(GO:0042347) |
0.0 | 1.4 | GO:0015985 | energy coupled proton transport, down electrochemical gradient(GO:0015985) ATP synthesis coupled proton transport(GO:0015986) |
0.0 | 0.7 | GO:0033623 | regulation of integrin activation(GO:0033623) |
0.0 | 1.1 | GO:0031954 | positive regulation of protein autophosphorylation(GO:0031954) |
0.0 | 0.1 | GO:1902623 | negative regulation of macrophage chemotaxis(GO:0010760) negative regulation of monocyte chemotaxis(GO:0090027) negative regulation of neutrophil migration(GO:1902623) |
0.0 | 0.1 | GO:1904098 | regulation of protein O-linked glycosylation(GO:1904098) positive regulation of protein O-linked glycosylation(GO:1904100) |
0.0 | 0.4 | GO:0006451 | selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
0.0 | 1.4 | GO:0034198 | cellular response to amino acid starvation(GO:0034198) |
0.0 | 0.6 | GO:0060732 | positive regulation of inositol phosphate biosynthetic process(GO:0060732) |
0.0 | 0.7 | GO:0046855 | inositol phosphate dephosphorylation(GO:0046855) |
0.0 | 0.8 | GO:0045717 | negative regulation of fatty acid biosynthetic process(GO:0045717) |
0.0 | 0.6 | GO:0008272 | sulfate transport(GO:0008272) |
0.0 | 0.1 | GO:0043328 | protein targeting to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043328) |
0.0 | 0.2 | GO:0090234 | regulation of kinetochore assembly(GO:0090234) |
0.0 | 0.8 | GO:0072311 | renal filtration cell differentiation(GO:0061318) glomerular epithelium development(GO:0072010) glomerular visceral epithelial cell differentiation(GO:0072112) glomerular epithelial cell differentiation(GO:0072311) |
0.0 | 1.4 | GO:0002042 | cell migration involved in sprouting angiogenesis(GO:0002042) |
0.0 | 0.8 | GO:0051639 | actin filament network formation(GO:0051639) |
0.0 | 0.6 | GO:0006107 | oxaloacetate metabolic process(GO:0006107) |
0.0 | 0.5 | GO:2000291 | regulation of myoblast proliferation(GO:2000291) |
0.0 | 0.7 | GO:0016226 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
0.0 | 0.5 | GO:0030322 | stabilization of membrane potential(GO:0030322) |
0.0 | 0.1 | GO:1904124 | negative regulation of norepinephrine secretion(GO:0010700) microglial cell migration(GO:1904124) regulation of microglial cell migration(GO:1904139) |
0.0 | 0.2 | GO:0032488 | Cdc42 protein signal transduction(GO:0032488) |
0.0 | 1.1 | GO:0032008 | activation of MAPKK activity(GO:0000186) positive regulation of TOR signaling(GO:0032008) |
0.0 | 0.1 | GO:0006434 | seryl-tRNA aminoacylation(GO:0006434) |
0.0 | 0.5 | GO:0042036 | negative regulation of cytokine biosynthetic process(GO:0042036) |
0.0 | 2.9 | GO:0009062 | fatty acid catabolic process(GO:0009062) |
0.0 | 0.1 | GO:0098942 | cytoskeletal matrix organization at active zone(GO:0048789) neurexin clustering involved in presynaptic membrane assembly(GO:0097115) retrograde trans-synaptic signaling by soluble gas(GO:0098923) retrograde trans-synaptic signaling by trans-synaptic protein complex(GO:0098942) trans-synaptic signaling by soluble gas(GO:0099543) |
0.0 | 2.1 | GO:1904893 | negative regulation of JAK-STAT cascade(GO:0046426) negative regulation of STAT cascade(GO:1904893) |
0.0 | 0.5 | GO:0051044 | positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
0.0 | 0.3 | GO:0006268 | DNA unwinding involved in DNA replication(GO:0006268) |
0.0 | 1.2 | GO:0010501 | RNA secondary structure unwinding(GO:0010501) |
0.0 | 0.2 | GO:0098914 | membrane repolarization during atrial cardiac muscle cell action potential(GO:0098914) |
0.0 | 0.3 | GO:0010807 | regulation of synaptic vesicle priming(GO:0010807) |
0.0 | 0.8 | GO:0006805 | xenobiotic metabolic process(GO:0006805) |
0.0 | 0.1 | GO:0070494 | regulation of thrombin receptor signaling pathway(GO:0070494) negative regulation of thrombin receptor signaling pathway(GO:0070495) |
0.0 | 0.6 | GO:0035987 | endodermal cell differentiation(GO:0035987) |
0.0 | 0.8 | GO:0051452 | intracellular pH reduction(GO:0051452) |
0.0 | 0.7 | GO:0010644 | cell communication by electrical coupling(GO:0010644) |
0.0 | 0.5 | GO:2000311 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000311) |
0.0 | 2.4 | GO:0006958 | complement activation, classical pathway(GO:0006958) |
0.0 | 4.3 | GO:0010466 | negative regulation of peptidase activity(GO:0010466) |
0.0 | 0.1 | GO:0051970 | negative regulation of transmission of nerve impulse(GO:0051970) |
0.0 | 0.2 | GO:1900016 | negative regulation of cytokine production involved in inflammatory response(GO:1900016) |
0.0 | 0.2 | GO:0006369 | termination of RNA polymerase II transcription(GO:0006369) |
0.0 | 0.2 | GO:0036158 | outer dynein arm assembly(GO:0036158) |
0.0 | 0.8 | GO:0016239 | endosome to lysosome transport(GO:0008333) positive regulation of macroautophagy(GO:0016239) |
0.0 | 0.3 | GO:0035235 | ionotropic glutamate receptor signaling pathway(GO:0035235) |
0.0 | 0.1 | GO:0015675 | nickel cation transport(GO:0015675) |
0.0 | 0.4 | GO:0021819 | layer formation in cerebral cortex(GO:0021819) |
0.0 | 0.1 | GO:1901837 | negative regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:1901837) |
0.0 | 0.1 | GO:0044336 | canonical Wnt signaling pathway involved in negative regulation of apoptotic process(GO:0044336) |
0.0 | 0.1 | GO:0048563 | post-embryonic organ morphogenesis(GO:0048563) |
0.0 | 0.0 | GO:0070340 | detection of triacyl bacterial lipopeptide(GO:0042495) detection of bacterial lipopeptide(GO:0070340) |
0.0 | 0.3 | GO:0035584 | calcium-mediated signaling using intracellular calcium source(GO:0035584) |
0.0 | 0.1 | GO:0098814 | spontaneous neurotransmitter secretion(GO:0061669) spontaneous synaptic transmission(GO:0098814) |
0.0 | 0.1 | GO:0060017 | parathyroid gland development(GO:0060017) |
0.0 | 0.5 | GO:0071625 | vocalization behavior(GO:0071625) |
0.0 | 0.1 | GO:0002457 | T cell antigen processing and presentation(GO:0002457) |
0.0 | 0.4 | GO:0032469 | endoplasmic reticulum calcium ion homeostasis(GO:0032469) |
0.0 | 2.3 | GO:0035023 | regulation of Rho protein signal transduction(GO:0035023) |
0.0 | 0.1 | GO:2000253 | positive regulation of feeding behavior(GO:2000253) |
0.0 | 0.3 | GO:1901798 | positive regulation of signal transduction by p53 class mediator(GO:1901798) |
0.0 | 0.1 | GO:0006977 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest(GO:0006977) |
0.0 | 10.8 | GO:0055114 | oxidation-reduction process(GO:0055114) |
0.0 | 0.1 | GO:0071447 | cellular response to hydroperoxide(GO:0071447) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.0 | 9.3 | GO:0031265 | CD95 death-inducing signaling complex(GO:0031265) |
1.0 | 4.9 | GO:0034365 | discoidal high-density lipoprotein particle(GO:0034365) |
0.9 | 13.8 | GO:0098533 | ATPase dependent transmembrane transport complex(GO:0098533) |
0.6 | 6.6 | GO:0097433 | dense body(GO:0097433) |
0.5 | 7.5 | GO:0031983 | vesicle lumen(GO:0031983) |
0.3 | 0.9 | GO:0098842 | postsynaptic early endosome(GO:0098842) |
0.3 | 2.7 | GO:0005579 | membrane attack complex(GO:0005579) |
0.3 | 1.4 | GO:0071953 | elastic fiber(GO:0071953) |
0.3 | 3.7 | GO:0098643 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
0.3 | 0.8 | GO:0098559 | cytoplasmic side of early endosome membrane(GO:0098559) |
0.2 | 0.7 | GO:0032311 | angiogenin-PRI complex(GO:0032311) |
0.2 | 3.2 | GO:0043203 | axon hillock(GO:0043203) |
0.2 | 1.4 | GO:0045261 | mitochondrial proton-transporting ATP synthase complex, catalytic core F(1)(GO:0000275) proton-transporting ATP synthase complex, catalytic core F(1)(GO:0045261) |
0.1 | 1.1 | GO:0071986 | Ragulator complex(GO:0071986) |
0.1 | 0.6 | GO:0000308 | cytoplasmic cyclin-dependent protein kinase holoenzyme complex(GO:0000308) |
0.1 | 0.7 | GO:0042583 | chromaffin granule(GO:0042583) |
0.1 | 0.9 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
0.1 | 2.6 | GO:0030014 | CCR4-NOT complex(GO:0030014) |
0.1 | 11.2 | GO:0016363 | nuclear matrix(GO:0016363) |
0.1 | 0.9 | GO:0060091 | kinocilium(GO:0060091) |
0.1 | 7.2 | GO:0005581 | collagen trimer(GO:0005581) |
0.1 | 0.7 | GO:0030991 | intraciliary transport particle A(GO:0030991) |
0.1 | 19.1 | GO:0072562 | blood microparticle(GO:0072562) |
0.1 | 0.1 | GO:0000814 | ESCRT II complex(GO:0000814) |
0.1 | 0.5 | GO:1990246 | uniplex complex(GO:1990246) |
0.1 | 0.5 | GO:0005827 | polar microtubule(GO:0005827) |
0.1 | 0.5 | GO:0031673 | H zone(GO:0031673) |
0.1 | 0.8 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
0.1 | 1.2 | GO:0005922 | connexon complex(GO:0005922) |
0.0 | 0.7 | GO:0000138 | Golgi trans cisterna(GO:0000138) |
0.0 | 32.1 | GO:0005764 | lytic vacuole(GO:0000323) lysosome(GO:0005764) |
0.0 | 0.3 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
0.0 | 0.2 | GO:0072534 | perineuronal net(GO:0072534) |
0.0 | 2.1 | GO:0032281 | AMPA glutamate receptor complex(GO:0032281) |
0.0 | 2.5 | GO:0048786 | presynaptic active zone(GO:0048786) |
0.0 | 0.3 | GO:0031205 | endoplasmic reticulum Sec complex(GO:0031205) |
0.0 | 10.9 | GO:0016324 | apical plasma membrane(GO:0016324) |
0.0 | 0.2 | GO:1990584 | cardiac Troponin complex(GO:1990584) |
0.0 | 3.2 | GO:0005901 | caveola(GO:0005901) |
0.0 | 7.9 | GO:0042579 | peroxisome(GO:0005777) microbody(GO:0042579) |
0.0 | 0.2 | GO:0097441 | basilar dendrite(GO:0097441) |
0.0 | 3.7 | GO:0000118 | histone deacetylase complex(GO:0000118) |
0.0 | 1.3 | GO:0005790 | smooth endoplasmic reticulum(GO:0005790) |
0.0 | 0.8 | GO:0033017 | sarcoplasmic reticulum membrane(GO:0033017) |
0.0 | 10.1 | GO:0016323 | basolateral plasma membrane(GO:0016323) |
0.0 | 0.6 | GO:0097225 | sperm midpiece(GO:0097225) |
0.0 | 3.7 | GO:0055037 | recycling endosome(GO:0055037) |
0.0 | 0.5 | GO:0031985 | Golgi cisterna(GO:0031985) |
0.0 | 12.6 | GO:0005789 | endoplasmic reticulum membrane(GO:0005789) |
0.0 | 0.2 | GO:0070847 | core mediator complex(GO:0070847) |
0.0 | 0.7 | GO:0030173 | integral component of Golgi membrane(GO:0030173) |
0.0 | 1.2 | GO:0005762 | organellar large ribosomal subunit(GO:0000315) mitochondrial large ribosomal subunit(GO:0005762) |
0.0 | 30.3 | GO:0005615 | extracellular space(GO:0005615) |
0.0 | 0.3 | GO:0042555 | MCM complex(GO:0042555) |
0.0 | 0.5 | GO:0016235 | aggresome(GO:0016235) |
0.0 | 0.2 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
0.0 | 0.4 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
0.0 | 18.6 | GO:0005783 | endoplasmic reticulum(GO:0005783) |
0.0 | 0.1 | GO:0002177 | manchette(GO:0002177) |
0.0 | 1.4 | GO:0005913 | cell-cell adherens junction(GO:0005913) |
0.0 | 0.6 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
0.0 | 0.7 | GO:0005758 | mitochondrial intermembrane space(GO:0005758) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.0 | 11.8 | GO:0004478 | methionine adenosyltransferase activity(GO:0004478) |
2.8 | 8.5 | GO:1901375 | acetylcholine transmembrane transporter activity(GO:0005277) norepinephrine transmembrane transporter activity(GO:0005333) acetate ester transmembrane transporter activity(GO:1901375) |
2.8 | 19.3 | GO:0018685 | alkane 1-monooxygenase activity(GO:0018685) |
2.3 | 9.3 | GO:0043120 | tumor necrosis factor binding(GO:0043120) |
2.1 | 8.4 | GO:0016822 | hydrolase activity, acting on acid carbon-carbon bonds(GO:0016822) hydrolase activity, acting on acid carbon-carbon bonds, in ketonic substances(GO:0016823) |
1.8 | 7.2 | GO:0008941 | nitric oxide dioxygenase activity(GO:0008941) oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of two atoms of oxygen into one donor(GO:0016708) iron-cytochrome-c reductase activity(GO:0047726) |
1.6 | 4.9 | GO:0046911 | metal chelating activity(GO:0046911) |
1.4 | 11.4 | GO:0050649 | testosterone 6-beta-hydroxylase activity(GO:0050649) |
1.4 | 4.1 | GO:0033754 | indoleamine 2,3-dioxygenase activity(GO:0033754) |
1.2 | 6.2 | GO:0033765 | steroid dehydrogenase activity, acting on the CH-CH group of donors(GO:0033765) |
0.9 | 6.6 | GO:0015091 | ferric iron transmembrane transporter activity(GO:0015091) trivalent inorganic cation transmembrane transporter activity(GO:0072510) |
0.9 | 2.7 | GO:0004967 | glucagon receptor activity(GO:0004967) |
0.8 | 3.1 | GO:0002114 | interleukin-33 receptor activity(GO:0002114) |
0.7 | 2.2 | GO:0001596 | angiotensin type I receptor activity(GO:0001596) |
0.7 | 8.9 | GO:0030976 | thiamine pyrophosphate binding(GO:0030976) |
0.7 | 18.3 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.6 | 3.0 | GO:0008761 | UDP-N-acetylglucosamine 2-epimerase activity(GO:0008761) |
0.6 | 1.8 | GO:0008480 | sarcosine dehydrogenase activity(GO:0008480) |
0.6 | 3.4 | GO:0003839 | gamma-glutamylcyclotransferase activity(GO:0003839) |
0.5 | 1.6 | GO:0005026 | transforming growth factor beta receptor activity, type II(GO:0005026) |
0.5 | 1.5 | GO:0004794 | L-threonine ammonia-lyase activity(GO:0004794) |
0.5 | 13.8 | GO:0017127 | cholesterol transporter activity(GO:0017127) |
0.5 | 4.6 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
0.4 | 1.8 | GO:0005021 | vascular endothelial growth factor-activated receptor activity(GO:0005021) |
0.3 | 2.0 | GO:0060175 | brain-derived neurotrophic factor-activated receptor activity(GO:0060175) |
0.3 | 1.6 | GO:0015183 | L-aspartate transmembrane transporter activity(GO:0015183) |
0.3 | 0.9 | GO:0052593 | tryptamine:oxygen oxidoreductase (deaminating) activity(GO:0052593) aminoacetone:oxygen oxidoreductase(deaminating) activity(GO:0052594) aliphatic-amine oxidase activity(GO:0052595) phenethylamine:oxygen oxidoreductase (deaminating) activity(GO:0052596) |
0.3 | 2.1 | GO:0019770 | IgG receptor activity(GO:0019770) |
0.3 | 5.2 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
0.3 | 3.3 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
0.3 | 1.1 | GO:0019809 | spermidine binding(GO:0019809) |
0.3 | 4.3 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
0.3 | 2.3 | GO:0061676 | importin-alpha family protein binding(GO:0061676) |
0.3 | 3.1 | GO:0015194 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
0.2 | 0.7 | GO:0046899 | nucleoside triphosphate adenylate kinase activity(GO:0046899) |
0.2 | 2.1 | GO:0016812 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides(GO:0016812) |
0.2 | 60.5 | GO:0008236 | serine-type peptidase activity(GO:0008236) |
0.2 | 5.2 | GO:0005537 | mannose binding(GO:0005537) |
0.2 | 2.1 | GO:0031433 | telethonin binding(GO:0031433) |
0.2 | 3.6 | GO:0016290 | palmitoyl-CoA hydrolase activity(GO:0016290) |
0.2 | 0.7 | GO:0008802 | betaine-aldehyde dehydrogenase activity(GO:0008802) |
0.2 | 5.1 | GO:0001871 | pattern binding(GO:0001871) polysaccharide binding(GO:0030247) |
0.2 | 1.0 | GO:0048248 | CXCR3 chemokine receptor binding(GO:0048248) |
0.2 | 1.2 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
0.2 | 3.9 | GO:0032041 | histone deacetylase activity (H3-K14 specific)(GO:0031078) NAD-dependent histone deacetylase activity (H3-K14 specific)(GO:0032041) |
0.2 | 2.7 | GO:0019841 | retinol binding(GO:0019841) |
0.2 | 1.4 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
0.2 | 1.1 | GO:0071532 | ankyrin repeat binding(GO:0071532) |
0.2 | 0.9 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) |
0.2 | 22.1 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.1 | 0.3 | GO:0005119 | smoothened binding(GO:0005119) hedgehog receptor activity(GO:0008158) |
0.1 | 1.3 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
0.1 | 0.4 | GO:0004373 | glycogen (starch) synthase activity(GO:0004373) |
0.1 | 3.5 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
0.1 | 0.4 | GO:0016314 | phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase activity(GO:0016314) |
0.1 | 0.4 | GO:0001847 | opsonin receptor activity(GO:0001847) |
0.1 | 1.0 | GO:0004366 | glycerol-3-phosphate O-acyltransferase activity(GO:0004366) |
0.1 | 0.5 | GO:0004711 | ribosomal protein S6 kinase activity(GO:0004711) |
0.1 | 2.5 | GO:0070513 | death domain binding(GO:0070513) |
0.1 | 0.6 | GO:0001595 | angiotensin receptor activity(GO:0001595) |
0.1 | 1.5 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
0.1 | 0.3 | GO:0004489 | methylenetetrahydrofolate reductase (NAD(P)H) activity(GO:0004489) |
0.1 | 1.9 | GO:0015143 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
0.1 | 0.7 | GO:0003835 | beta-galactoside alpha-2,6-sialyltransferase activity(GO:0003835) |
0.1 | 0.7 | GO:1903763 | gap junction channel activity involved in cell communication by electrical coupling(GO:1903763) |
0.1 | 2.1 | GO:0005003 | ephrin receptor activity(GO:0005003) |
0.1 | 0.6 | GO:0004515 | nicotinamide-nucleotide adenylyltransferase activity(GO:0000309) nicotinate-nucleotide adenylyltransferase activity(GO:0004515) |
0.1 | 0.6 | GO:0050610 | oxidoreductase activity, acting on phosphorus or arsenic in donors(GO:0030613) oxidoreductase activity, acting on phosphorus or arsenic in donors, disulfide as acceptor(GO:0030614) glutathione dehydrogenase (ascorbate) activity(GO:0045174) methylarsonate reductase activity(GO:0050610) |
0.1 | 0.3 | GO:0005260 | channel-conductance-controlling ATPase activity(GO:0005260) |
0.1 | 1.6 | GO:0015250 | water channel activity(GO:0015250) |
0.1 | 0.7 | GO:0008428 | ribonuclease inhibitor activity(GO:0008428) |
0.1 | 3.6 | GO:0015020 | glucuronosyltransferase activity(GO:0015020) |
0.1 | 0.8 | GO:0004768 | stearoyl-CoA 9-desaturase activity(GO:0004768) |
0.1 | 0.6 | GO:0047035 | testosterone dehydrogenase (NAD+) activity(GO:0047035) |
0.1 | 3.9 | GO:0030332 | cyclin binding(GO:0030332) |
0.1 | 0.2 | GO:0005324 | long-chain fatty acid transporter activity(GO:0005324) |
0.1 | 1.4 | GO:0046933 | proton-transporting ATP synthase activity, rotational mechanism(GO:0046933) |
0.1 | 1.7 | GO:0019825 | oxygen binding(GO:0019825) |
0.1 | 1.2 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
0.1 | 0.9 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
0.1 | 1.0 | GO:0038036 | sphingosine-1-phosphate receptor activity(GO:0038036) |
0.1 | 0.9 | GO:0019957 | C-C chemokine binding(GO:0019957) |
0.1 | 6.3 | GO:0005518 | collagen binding(GO:0005518) |
0.1 | 0.2 | GO:0070890 | L-ascorbate:sodium symporter activity(GO:0008520) L-ascorbic acid transporter activity(GO:0015229) sodium-dependent L-ascorbate transmembrane transporter activity(GO:0070890) |
0.1 | 1.2 | GO:0003841 | 1-acylglycerol-3-phosphate O-acyltransferase activity(GO:0003841) |
0.1 | 0.6 | GO:0050786 | RAGE receptor binding(GO:0050786) |
0.1 | 1.8 | GO:0043274 | phospholipase binding(GO:0043274) |
0.1 | 1.0 | GO:0008484 | sulfuric ester hydrolase activity(GO:0008484) |
0.1 | 0.4 | GO:0042030 | ATPase inhibitor activity(GO:0042030) |
0.1 | 0.3 | GO:0005483 | soluble NSF attachment protein activity(GO:0005483) |
0.1 | 1.6 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
0.1 | 1.4 | GO:0098641 | cadherin binding involved in cell-cell adhesion(GO:0098641) |
0.1 | 0.7 | GO:0042731 | PH domain binding(GO:0042731) |
0.1 | 0.4 | GO:0071617 | lysophospholipid acyltransferase activity(GO:0071617) |
0.0 | 0.4 | GO:0005243 | gap junction channel activity(GO:0005243) |
0.0 | 0.5 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.0 | 0.7 | GO:0015643 | toxic substance binding(GO:0015643) |
0.0 | 0.4 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
0.0 | 0.8 | GO:0015923 | alpha-mannosidase activity(GO:0004559) mannosidase activity(GO:0015923) |
0.0 | 1.1 | GO:0031005 | filamin binding(GO:0031005) |
0.0 | 6.8 | GO:0043492 | ATPase activity, coupled to movement of substances(GO:0043492) |
0.0 | 0.2 | GO:0033142 | progesterone receptor binding(GO:0033142) |
0.0 | 2.1 | GO:0043531 | ADP binding(GO:0043531) |
0.0 | 2.4 | GO:0030544 | Hsp70 protein binding(GO:0030544) |
0.0 | 2.1 | GO:0015485 | cholesterol binding(GO:0015485) |
0.0 | 0.2 | GO:0031013 | troponin C binding(GO:0030172) troponin I binding(GO:0031013) |
0.0 | 0.4 | GO:0017151 | DEAD/H-box RNA helicase binding(GO:0017151) |
0.0 | 0.6 | GO:0019531 | oxalate transmembrane transporter activity(GO:0019531) |
0.0 | 0.6 | GO:0015125 | bile acid transmembrane transporter activity(GO:0015125) |
0.0 | 0.1 | GO:0001962 | alpha-1,3-galactosyltransferase activity(GO:0001962) |
0.0 | 0.1 | GO:0004828 | serine-tRNA ligase activity(GO:0004828) |
0.0 | 0.5 | GO:0022841 | potassium ion leak channel activity(GO:0022841) |
0.0 | 1.0 | GO:0008483 | transaminase activity(GO:0008483) |
0.0 | 0.1 | GO:0052834 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate 3-phosphatase activity(GO:0052832) inositol monophosphate 4-phosphatase activity(GO:0052833) inositol monophosphate phosphatase activity(GO:0052834) |
0.0 | 0.3 | GO:0016634 | oxidoreductase activity, acting on the CH-CH group of donors, oxygen as acceptor(GO:0016634) |
0.0 | 3.9 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
0.0 | 0.1 | GO:0004169 | dolichyl-phosphate-mannose-protein mannosyltransferase activity(GO:0004169) |
0.0 | 0.4 | GO:0015269 | calcium-activated potassium channel activity(GO:0015269) |
0.0 | 2.4 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
0.0 | 0.1 | GO:0004370 | glycerol kinase activity(GO:0004370) |
0.0 | 0.4 | GO:0016594 | glycine binding(GO:0016594) |
0.0 | 1.2 | GO:0003743 | translation initiation factor activity(GO:0003743) |
0.0 | 0.1 | GO:0004111 | creatine kinase activity(GO:0004111) |
0.0 | 0.1 | GO:0015099 | nickel cation transmembrane transporter activity(GO:0015099) |
0.0 | 0.4 | GO:0097602 | cullin family protein binding(GO:0097602) |
0.0 | 0.3 | GO:0001608 | G-protein coupled nucleotide receptor activity(GO:0001608) G-protein coupled purinergic nucleotide receptor activity(GO:0045028) |
0.0 | 0.8 | GO:0050699 | WW domain binding(GO:0050699) |
0.0 | 1.1 | GO:0019894 | kinesin binding(GO:0019894) |
0.0 | 0.8 | GO:0019003 | GDP binding(GO:0019003) |
0.0 | 0.2 | GO:0031210 | phosphatidylcholine binding(GO:0031210) |
0.0 | 2.2 | GO:0016853 | isomerase activity(GO:0016853) |
0.0 | 0.3 | GO:0004707 | MAP kinase activity(GO:0004707) MAP kinase kinase activity(GO:0004708) |
0.0 | 0.3 | GO:0043395 | heparan sulfate proteoglycan binding(GO:0043395) |
0.0 | 1.1 | GO:0032947 | protein complex scaffold(GO:0032947) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.6 | 9.4 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.3 | 1.8 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.2 | 11.7 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.2 | 7.2 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.1 | 4.6 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.1 | 30.5 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.1 | 1.8 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
0.1 | 5.2 | NABA COLLAGENS | Genes encoding collagen proteins |
0.1 | 0.5 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
0.1 | 2.0 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.1 | 2.4 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.0 | 1.3 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.0 | 9.3 | NABA CORE MATRISOME | Ensemble of genes encoding core extracellular matrix including ECM glycoproteins, collagens and proteoglycans |
0.0 | 1.0 | PID S1P S1P2 PATHWAY | S1P2 pathway |
0.0 | 3.2 | PID BCR 5PATHWAY | BCR signaling pathway |
0.0 | 5.0 | PID CMYB PATHWAY | C-MYB transcription factor network |
0.0 | 1.2 | PID EPHA FWDPATHWAY | EPHA forward signaling |
0.0 | 1.3 | PID HIV NEF PATHWAY | HIV-1 Nef: Negative effector of Fas and TNF-alpha |
0.0 | 0.4 | PID ALK2 PATHWAY | ALK2 signaling events |
0.0 | 0.9 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
0.0 | 2.2 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
0.0 | 0.9 | PID IL23 PATHWAY | IL23-mediated signaling events |
0.0 | 1.7 | PID SHP2 PATHWAY | SHP2 signaling |
0.0 | 5.1 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.0 | 0.6 | PID EPHB FWD PATHWAY | EPHB forward signaling |
0.0 | 1.7 | PID ERBB1 DOWNSTREAM PATHWAY | ErbB1 downstream signaling |
0.0 | 0.3 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.0 | 0.4 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.0 | 14.2 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
0.8 | 23.9 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
0.6 | 8.5 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
0.6 | 2.9 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
0.6 | 13.8 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
0.5 | 9.3 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.5 | 7.9 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
0.4 | 9.8 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 7ALPHA HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol |
0.4 | 8.9 | REACTOME PEROXISOMAL LIPID METABOLISM | Genes involved in Peroxisomal lipid metabolism |
0.3 | 11.1 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
0.3 | 4.6 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.2 | 2.6 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
0.2 | 3.8 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
0.2 | 2.0 | REACTOME NGF SIGNALLING VIA TRKA FROM THE PLASMA MEMBRANE | Genes involved in NGF signalling via TRKA from the plasma membrane |
0.2 | 1.8 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.2 | 8.5 | REACTOME METABOLISM OF STEROID HORMONES AND VITAMINS A AND D | Genes involved in Metabolism of steroid hormones and vitamins A and D |
0.1 | 1.9 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.1 | 2.7 | REACTOME COMPLEMENT CASCADE | Genes involved in Complement cascade |
0.1 | 2.9 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
0.1 | 1.8 | REACTOME ABC FAMILY PROTEINS MEDIATED TRANSPORT | Genes involved in ABC-family proteins mediated transport |
0.1 | 1.8 | REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
0.1 | 5.4 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.1 | 0.4 | REACTOME ACYL CHAIN REMODELLING OF PI | Genes involved in Acyl chain remodelling of PI |
0.1 | 1.4 | REACTOME FORMATION OF ATP BY CHEMIOSMOTIC COUPLING | Genes involved in Formation of ATP by chemiosmotic coupling |
0.1 | 1.8 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.1 | 1.6 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.1 | 3.5 | REACTOME GLUCAGON TYPE LIGAND RECEPTORS | Genes involved in Glucagon-type ligand receptors |
0.1 | 1.2 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
0.1 | 3.0 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
0.1 | 2.3 | REACTOME SYNTHESIS OF PA | Genes involved in Synthesis of PA |
0.0 | 3.8 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
0.0 | 0.1 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |
0.0 | 0.6 | REACTOME TRANSPORT OF ORGANIC ANIONS | Genes involved in Transport of organic anions |
0.0 | 2.2 | REACTOME PHASE1 FUNCTIONALIZATION OF COMPOUNDS | Genes involved in Phase 1 - Functionalization of compounds |
0.0 | 0.8 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
0.0 | 0.9 | REACTOME TRAFFICKING OF GLUR2 CONTAINING AMPA RECEPTORS | Genes involved in Trafficking of GluR2-containing AMPA receptors |
0.0 | 0.3 | REACTOME THE ACTIVATION OF ARYLSULFATASES | Genes involved in The activation of arylsulfatases |
0.0 | 0.9 | REACTOME PECAM1 INTERACTIONS | Genes involved in PECAM1 interactions |
0.0 | 0.7 | REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
0.0 | 0.7 | REACTOME HS GAG DEGRADATION | Genes involved in HS-GAG degradation |
0.0 | 1.5 | REACTOME GLUCONEOGENESIS | Genes involved in Gluconeogenesis |
0.0 | 1.5 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.0 | 2.3 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
0.0 | 0.4 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
0.0 | 0.8 | REACTOME ENOS ACTIVATION AND REGULATION | Genes involved in eNOS activation and regulation |
0.0 | 1.4 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
0.0 | 0.7 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
0.0 | 2.2 | REACTOME MHC CLASS II ANTIGEN PRESENTATION | Genes involved in MHC class II antigen presentation |
0.0 | 0.7 | REACTOME SMAD2 SMAD3 SMAD4 HETEROTRIMER REGULATES TRANSCRIPTION | Genes involved in SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription |
0.0 | 0.5 | REACTOME TRAFFICKING OF AMPA RECEPTORS | Genes involved in Trafficking of AMPA receptors |
0.0 | 0.2 | REACTOME ROLE OF SECOND MESSENGERS IN NETRIN1 SIGNALING | Genes involved in Role of second messengers in netrin-1 signaling |
0.0 | 0.3 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
0.0 | 0.3 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
0.0 | 0.2 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
0.0 | 0.5 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
0.0 | 0.3 | REACTOME P2Y RECEPTORS | Genes involved in P2Y receptors |
0.0 | 0.4 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |